SAB Biotherapeutics Inc
SAB Biotherapeutics Inc Stock, NASDAQ:SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The company produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton and is headquartered in Sioux Falls, SD.